Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Immunology and Cell Biology|February 1, 1995
T cell receptor V alpha bias can be determined by TCR-contact residues within an MHC-bound peptideS J Sterry, J M Kelly, S J Turner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1989
Somatostatin analogues in diabetes mellitusR R Davies, S J Turner, K G Alberti, et al.
British Medical Journal|December 15, 1973
Variation in plasma calcium with induced changes in plasma specific gravity, total protein, and albuminE M Berry, M M Gupta, S J Turner, et al.
Clinical Endocrinology|November 1, 1984
The response of normal subjects and patients with idiopathic growth hormone deficiency to continuous infusion of human pancreatic growth hormone releasing factor 1-44R R Davies, S J Turner, J M Parkin, et al.
Genes and Immunity|April 11, 2001
IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanomaW M Howell, S J Turner, A C Bateman, et al.
The Journal of Laryngology and Otology|September 25, 2009
Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsiteS J Turner, G J Morgan, C E Palme, et al.
The Journal of Biological Chemistry|September 25, 1998
The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alphaS J Turner, J Domin, M D Waterfield, et al.
The American Journal of Clinical Nutrition|July 1, 1976
Utilization of a low-lactose milkS J Turner, T Daly, J A Hourigan, et al.
Clinical Endocrinology|November 1, 1985
The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44R R Davies, S J Turner, D Cook, et al.
Genes and Immunity|June 12, 2002
Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanomaW M Howell, A C Bateman, S J Turner, et al.
Pageof 7